Colorectal Cancer

References

Adams WJ, Lawson JA et al. The growth of carcinogen-induced colon cancer in rats is inhibited by cimetidine. Eur J Surg Oncol. 1993 Aug;19(4):332-5.

Adams WJ, Lawson JA et al. Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth. Gut. 1994a Nov;35(11):1632-6.

Adams WJ, Morris DL. Short-course cimetidine and survival with colorectal cancer. Lancet. 1994b Dec 24;344(8939-8940):1768-9.

Aggarwal BB, Kumar A et al. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 2003 Jan;23(1A):363-98.

Akiyama Y, Tsubouchi N et al. Frequent somatic mutations of hMSH3 with reference to microsatellite instability in hereditary nonpolyposis colorectal cancers. Biochem Biophys Res Commun. 1997 Jul 18;236(2):248-52.

Al Taie OH, Seufert J et al. Selenium supplementation enhances low selenium levels and stimulates glutathione peroxidase activity in peripheral blood and distal colon mucosa in past and present carriers of colon adenomas. Nutr Cancer. 2003;46(2):125-30.

Alvarez-Dolado M, Gonzalez-Sancho JM et al. Retinoic acid and 1,25-dihydroxyvitamin D3 inhibit tenascin-C expression in rat glioma C6 cells. J Neurosci Res. 1999 Oct 15;58(2):293-300.

Anti M, Armelao F et al. Effects of different doses of fish oil on rectal cell proliferation in patients with sporadic colonic adenomas. Gastroenterology. 1994 Dec;107(6):1709-18.

Armstrong B, Doll R. Environmental factors and cancer incidence and mortality in different countries, with special reference to dietary practices. Int J Cancer. 1975 Apr 15;15(4):617-31.

Atkins JN, Jacobs SA et al. Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program. Clin Colorectal Cancer. 2005 Sep;5(3):181-7.

August DA, Landau J et al. Ingestion of green tea rapidly decreases prostaglandin E2 levels in rectal mucosa in humans. Cancer Epidemiol Biomarkers Prev. 1999 Aug;8(8):709-13.

Aziz MH, Kumar R et al. Cancer chemoprevention by resveratrol: in vitro and in vivo studies and the underlying mechanisms (review). Int J Oncol. 2003 Jul;23(1):17-28.

Bai D, Yang G et al. Perioperative cimetidine application modulates natural killer cells in patients with colorectal cancer: a randomized clinical study. J Tongji Med Univ. 1999;19(4):300-3.

Barber MD, Fearon KC. Tolerance and incorporation of a high-dose eicosapentaenoic acid diester emulsion by patients with pancreatic cancer cachexia. Lipids. 2001 Apr;36(4):347-51.

Baron JA, Beach M et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. 1999;340(2):101-7.

Baron JA, Cole BF. et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 6;348(10):891-9.

Bartram HP, Gostner A et al. Missing anti-proliferative effect of fish oil on rectal epithelium in healthy volunteers consuming a high-fat diet: potential role of the n-3:n-6 fatty acid ratio. Eur J Cancer Prev. 1995 Jun;4(3):231-7.

Belluco C, Nitti D et al. Interleukin-6 blood level is associated with circulating carcinoembryonic antigen and prognosis in patients with colorectal cancer. Ann Surg Oncol. 2000 Mar;7(2):133-8.

Ben-Arye E, Goldin E et al. Wheat grass juice in the treatment of active distal ulcerative colitis: a randomized double-blind placebo-controlled trial. Scand J Gastroenterol. 2002 Apr;37(4):444-9.

Bingham S. The fibre-folate debate in colo-rectal cancer. Proc Nutr Soc. 2006 Feb;65(1):19-23.

Bingham SA, Pignatelli B et al. Does increased endogenous formation of N-nitroso compounds in the human colon explain the association between red meat and colon cancer? Carcinogenesis. 1996 Mar;17(3):515-23.

Bird CL, Witte JS et al. Plasma ferritin, iron intake, and the risk of colorectal polyps. Am J Epidemiol. 1996 Jul 1;144(1):34-41.

Boari C, Montanari FM et al. [Toxic occupational liver diseases. Therapeutic effects of silymarin] Minerva Med. 1981 Oct 20;72(40):2679-88.

Boutron MC, Faivre J et al. Family history of colorectal tumours and implications for the adenoma-carcinoma sequence: a case control study. Gut. 1995 Dec;37(6):830-4.

Braga M, Gianotti L et al. Preoperative oral arginine and n-3 fatty acid supplementation improves the immunometabolic host response and outcome after colorectal resection for cancer. Surgery. 2002 Nov;132(5):805-14.

Breuer-Katschinski B, Nemes K et al. Relation of serum antioxidant vitamins to the risk of colorectal adenoma. Digestion. 2001;63(1):43-8.

Broitman SA, Wilkinson J et al. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv Exp Med Biol. 1995;401:111-30.

Broll R, Erdmann H et al. [Determination of vascular endothelial growth factor (VEGF) concentration in serum of patients with colorectal carcinoma] 353. Langenbecks Arch Chir Suppl Kongressbd. 1998;115(Suppl I):315-8.

Brouet I, Ohshima H. Curcumin, an anti-tumour promoter and anti-inflammatory agent, inhibits induction of nitric oxide synthase in activated macrophages. Biochem Biophys Res Commun. 1995 Jan 17;206(2):533-40.

Bruera E, Strasser F et al. Effect of fish oil on appetite and other symptoms in patients with advanced cancer and anorexia/cachexia: a double-blind, placebo-controlled study. J Clin Oncol. 2003 Jan 1;21(1):129-34.

Bukin YUV, Draudin-Krylenko VA et al. The effect of high doses of folic acid on the overexpression of ornithine decarboxylase and S-adenosylmethionine content in human colon adenomatous polyps. Ann N Y Acad Sci. 2001 Dec;952:175-6.

Burns CP, Halabi S et al. Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473. Clin Cancer Res. 1999 Dec;5(12):3942-7.

Bussey HJ. Familial polyposis coli and hepatocellular neoplasms. Hepatology. 1990 Jul;12(1):175-6.

Campbell S, Stone W et al. Development of gamma (gamma)-tocopherol as a colorectal cancer chemopreventive agent. Crit Rev Oncol Hematol. 2003 Sep;47(3):249-59.

Carriquiry LA, Pineyro A. Should carcinoembryonic antigen be used in the management of patients with colorectal cancer? Dis Colon Rectum. 1999 Jul;42(7):921-9.

Castagnola P, Giaretti W. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer. Biochim Biophys Acta. 2005 Nov 25;1756(2):115-25.

Castellone MD, Teramoto H. et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005 Dec 2;310(5753):1504-10.

Cats A, Kleibeuker JH et al. Randomized, double-blinded, placebo-controlled intervention study with supplemental calcium in families with hereditary nonpolyposis colorectal cancer. J Natl Cancer Inst. 1995 Apr 19;87(8):598-603.

Chan TA. Prostaglandins and the colon cancer connection. Trends Mol Med. 2006 Apr 28.

Chan TA, Morin PJ et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20;95(2):681-6.

Chauhan DP. Chemotherapeutic potential of curcumin for colorectal cancer. Curr Pharm Des. 2002;8(19):1695-706.

Chen C, Shen G et al. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells. Carcinogenesis. 2003 Aug;24(8):1369-78.

Chu KC, Tarone RE et al. Temporal patterns in colorectal cancer incidence, survival, and mortality from 1950 through 1990. J Natl Cancer Inst. 1994 Jul 6;86(13):997-1006.

Collett ED, Davidson LA et al. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol. 2001 May;280(5):C1066-C1075.

Collett JA, Platell C et al. Distal colonic neoplasms predict proximal neoplasia in average-risk, asymptomatic subjects. J Gastroenterol Hepatol. 1999 Jan;14(1):67-71.

Connelly-Frost A, Poole C et al. Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):486-93.

Corpet DE, Pierre F. Point: From animal models to prevention of colon cancer. Systematic review of chemoprevention in min mice and choice of the model system. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):391-400.

Cravo M, Fidalgo P et al. DNA methylation as an intermediate biomarker in colorectal cancer: modulation by folic acid supplementation. Eur J Cancer Prev. 1994 Nov;3(6):473-9.

Cravo ML, Pinto AG et al. Effect of folate supplementation on DNA methylation of rectal mucosa in patients with colonic adenomas: correlation with nutrient intake. Clin Nutr. 1998 Apr;17(2):45-9.

Cuendet M, Pezzuto JM. The role of cyclooxygenase and lipoxygenase in cancer chemoprevention. Drug Metabol Drug Interact. 2000;17(1-4):109-57.

Dalerba P, Maccalli C et al. Immunology and immunotherapy of colorectal cancer. Crit Rev Oncol Hematol. 2003 Apr;46(1):33-57.

Dashwood RH. Early detection and prevention of colorectal cancer (review). Oncol Rep. 1999 Mar;6(2):277-81.

Davis BC, Kris-Etherton PM. Achieving optimal essential fatty acid status in vegetarians: current knowledge and practical implications. Am J Clin Nutr. 2003 Sep;78(3 Suppl):640S-646S. Review.

Davis CD, Uthus EO. Dietary folate and selenium affect dimethylhydrazine-induced aberrant crypt formation, global DNA methylation and one-carbon metabolism in rats. J Nutr. 2003 Sep;133(9):2907-14.

Delmas D, Passilly-Degrace P et al. Resveratrol, a chemopreventive agent, disrupts the cell cycle control of human SW480 colorectal tumor cells. Int J Mol Med. 2002 Aug;10(2):193-9.

Dietlein M, Weber W et al. [18F-Fluorodeoxyglucose positron emission tomography in restaging of colorectal cancer]. Nuklearmedizin. 2003 Aug;42(4):145-56.

Donovan JM, Syngal S. Colorectal cancer in women: an underappreciated but preventable risk. J Womens Health. 1998 Feb;7(1):45-8.

Doxey BW, Kuwada SK et al. Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol. 2005 Jul;3(7):633-41.

Duffy MJ, van Dalen A et al. Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer. 2003 Apr;39(6):718-27.

Eberhart CE, Coffey RJ et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994 Oct;107(4):1183-8.

Evans RC, Fear S et al. Diet and colorectal cancer: an investigation of the lectin/galactose hypothesis. Gastroenterology. 2002 Jun;122(7):1784-92.

Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer]. Orv Hetil. 2005 Sep 11;146(37):1925-31.

Feinberg AP, Vogelstein B. Hypomethylation of ras oncogenes in primary human cancers. Biochem Biophys Res Commun. 1983 Feb 28;111(1):47-54.

Ferencik M, Ebringer L. Modulatory effects of selenium and zinc on the immune system. Folia Microbiol (Praha). 2003;48(3):417-26.

Fernandez-Banares F, Cabre E et al. Serum selenium and risk of large size colorectal adenomas in a geographical area with a low selenium status. Am J Gastroenterol. 2002 Aug;97(8):2103-8.

Finley JW. Bioavailability of selenium from foods. Nutr Rev. 2006 Mar;64(3):146-51.

Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res. 2002 May;22(3):1737-54.

Fleet JC. Dietary selenium repletion may reduce cancer incidence in people at high risk who live in areas with low soil selenium. Nutr Rev. 1997 Jul;55(7):277-9.

Foutch PG, DiSario JA et al. The sentinel hyperplastic polyp: a marker for synchronous neoplasia in the proximal colon. Am J Gastroenterol. 1991 Oct;86(10):1482-5.

Franceschi S, Dal Maso L, et al. Dietary glycemic load and colorectal cancer risk. Ann Oncol. 2001 Feb;12(2):173-8.

Fujiki H, Suganuma M et al. Cancer inhibition by green tea. Mutat Res. 1998 Jun 18;402(1-2):307-10.

Gao C, Ding Z et al. [Study on the effects of curcumin on angiogenesis]. Zhong Yao Cai. 2003 Jul;26(7):499-502.

Garami M, Schuler D et al. Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J Pediatr Hematol Oncol. 2004 Oct;26(10):631-5.

Garcea G, Berry DP et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5.

Garland CF, Garland FC et al. Calcium and vitamin D. Their potential roles in colon and breast cancer prevention. Ann N Y Acad Sci. 1999;889:107-19.

Gelb MH, Tamanoi F et al. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett. 1995;91(2):169-75.

Gerhardsson de V, Hagman U et al. Meat, cooking methods and colorectal cancer: a case-referent study in Stockholm. Int J Cancer. 1991 Oct 21;49(4):520-5.

Gescher A. Polyphenolic phytochemicals versus non-steroidal anti-inflammatory drugs: which are better cancer chemopreventive agents? J Chemother. 2004 Nov;16 Suppl 4:3-6. Review.

Giardiello FM, Hamilton SR et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med. 1993 May 6;328(18):1313-6.

Giess CS, Schwartz LH et al. Patterns of neoplastic spread in colorectal cancer: implications for surveillance CT studies. AJR Am J Roentgenol. 1998 Apr;170(4):987-91.

Giovannucci E, Colditz GA et al. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control. 1996a Mar;7(2):253-63.

Giovannucci E, Martinez ME. Tobacco, colorectal cancer, and adenomas: a review of the evidence. J Natl Cancer Inst. 1996b Dec 4;88(23):1717-30. Review.

Giovannucci E, Stampfer MJ et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med. 1998 Oct 1;129(7):517-24.

Giovannucci E. Epidemiologic studies of folate and colorectal neoplasia: a review. J Nutr. 2002 Aug;132(8 Suppl):2350S-2355S.

Giovannucci E, Chen J et al. Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2003 Oct;12(10):970-9.

Glinghammar B, Holmberg K et al. Effects of colonic lumenal components on AP-1-dependent gene transcription in cultured human colon carcinoma cells 3. Carcinogenesis. 1999 Jun;20(6):969-76.

Glinskii OV, Huxley VH et al. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia. 2005 May;7(5):522-7.

Gogos CA, Ginopoulos P et al. Dietary omega-3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy: a randomized control trial. Cancer. 1998 Jan 15;82(2):395-402.

Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006 Feb;9(1A):124-6.

Grau MV, Baron JA et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst. 2003 Dec 3;95(23):1765-71.

Greenwald P, Lanza E. Dietary fiber and colon cancer. Bol Asoc Med P R. 1986 Jul;78(7):311-3.

Griesenberg D, Nurnberg R et al. CEA, TPS, CA 19-9 and CA 72-4 and the fecal occult blood test in the preoperative diagnosis and follow-up after resective surgery of colorectal cancer. Anticancer Res. 1999 Jul;19(4A):2443-50.

Grimm H, Mayer K et al. Regulatory potential of n-3 fatty acids in immunological and inflammatory processes. Br J Nutr. 2002 Jan;87 Suppl 1:S59-S67.

Grossman S, Milos ML. Colonoscopic screening of persons with suspected risk factors for colon cancer. I. Family history. Gastroenterology. 1988 Feb;94(2):395-400.

Gururaj AE, Belakavadi M et al. Molecular mechanisms of anti-angiogenic effect of curcumin. Biochem Biophys Res Commun. 2002 Oct 4;297(4):934-42.

Hahnfeldt P, Folkman J et al. Minimizing long-term tumor burden: the logic for metronomic chemotherapeutic dosing and its antiangiogenic basis. J Theor Biol. 2003 Feb 21;220(4):545-54.

Hanif R, Pittas A. et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol. 1996 Jul 26;52(2):237-45.

Hanrahan V, Currie MJ et al. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression. J Pathol. 2003 Jun;200(2):183-94.

Hansbrough JF, Zapata-Sirvent RL et al. Prevention of alterations in postoperative lymphocyte subpopulations by cimetidine and ibuprofen. Am J Surg. 1986 Feb;151(2):249-55.

Hayashi A, Gillen AC et al. Effects of daily oral administration of quercetin chalcone and modified citrus pectin on implanted colon-25 tumor growth in Balb-c mice. Altern Med Rev. 2000 Dec;5(6):546-52.

He TC, Chan TA. et al. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 Oct 29a;99(3):335-45.

Hidvegi M, Raso E et al. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 1998 Jul;18(4A):2353-8.

Hidvegi M, Raso E et al. MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer Biother Radiopharm. 1999 Aug;14(4):277-89.

Hofstad B, Almendingen K et al. Growth and recurrence of colorectal polyps: a double-blind 3-year intervention with calcium and antioxidants. Digestion. 1998;59(2):148-56.

Holla VR, Mann JR. et al. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006 Feb 3;281(5):2676-82.

Hong J, Smith TJ et al. Effects of purified green and black tea polyphenols on cyclooxygenase- and lipoxygenase-dependent metabolism of arachidonic acid in human colon mucosa and colon tumor tissues. Biochem Pharmacol. 2001 Nov 1;62(9):1175-83.

Hori H, Nakata H et al. Oncogenic ras induces gastrin/CCKB receptor gene expression in human colon cancer cell lines LoVo and Colo320HSR. J Lab Clin Med. 2003 May;141(5):335-41.

Howe GR, Benito E et al. Dietary intake of fiber and decreased risk of cancers of the colon and rectum: evidence from the combined analysis of 13 case-control studies. J Natl Cancer Inst. 1992 Dec 16;84(24):1887-96.

Ichikawa D, Takahashi T et al. [Postoperative management of the preserved rectal segment in patients with familial polyposis: the use of 5-fluorouracil suppositories and green tea extract to inhibit tumor growth]. Nippon Geka Gakkai Zasshi. 1998 Jun;99(6):391-5.

Ide T, Horii M et al. Contrasting effects of water-soluble and water-insoluble dietary fibers on bile acid conjugation and taurine metabolism in the rat. Lipids. 1990 Jun;25(6):335-40.

Illmer C, Madlener S et al. Immunologic and biochemical effects of the fermented wheat germ extract Avemar. Exp Biol Med (Maywood ). 2005 Feb;230(2):144-9.

Ip C, Hayes C et al. Chemical form of selenium, critical metabolites, and cancer prevention. Cancer Res. 1991 Jan 15;51(2):595-600.

Iwamoto S, Senzaki H et al. Effects of fatty acids on liver metastasis of ACL-15 rat colon cancer cells. Nutr Cancer. 1998;31(2):143-50.

Ishikawa H, Saeki T. et al. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 2006 Mar;136(3 Suppl):816S-820S.

Jakab F, Mayer A et al. First clinical data of a natural immunomodulator in colorectal cancer. Hepatogastroenterology. 2000 Mar;47(32):393-5.

Jakab F, Shoenfeld Y et al. A medical nutriment has supportive value in the treatment of colorectal cancer. Br J Cancer. 2003 Aug 4;89(3):465-9.

Jaiswal AS, Marlow BP et al. Beta-catenin-mediated transactivation and cell-cell adhesion pathways are important in curcumin (diferuylmethane)-induced growth arrest and apoptosis in colon cancer cells. Oncogene. 2002 Dec 5;21(55):8414-27.

Jalving M, Koornstra JJ et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15;21(4):321-39.

Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. 2000 Jun 29;342(26):1960-8.

Jiao Y, Wilkinson J et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006 Apr 1;40(7):1152-60.

Johansson G, Holmen A et al. Dietary influence on some proposed risk factors for colon cancer: fecal and urinary mutagenic activity and the activity of some intestinal bacterial enzymes. Cancer Detect Prev. 1997;21(3):258-66.

Jones R, Adel-Alvarez LA et al. Arachidonic acid and colorectal carcinogenesis. Mol Cell Biochem. 2003 Nov;253(1-2):141-9.

Jubb AM, Hurwitz HI et al. Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol. 2006 Jan 10;24(2):217-27.

Jung YD, Kim MS et al. EGCG, a major component of green tea, inhibits tumour growth by inhibiting VEGF induction in human colon carcinoma cells. Br J Cancer. 2001a Mar 23;84(6):844-50.

Jung YD, Ellis LM. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea. Int J Exp Pathol. 2001b Dec;82(6):309-16.

Kahl-Rainer P, Marian B. Retinoids inhibit protein kinase C-dependent transduction of 1,2-diglyceride signals in human colonic tumor cells. Nutr Cancer. 1994;21(2):157-68.

Kalantzis C, Markoglou C et al. Endoscopic ultrasonography in the preoperative staging of colorectal cancer. Hepatogastroenterology. 2002 May;49(45):683-6.

Kamano T, Mikami Y et al. Ratio of primary and secondary bile acids in feces: possible marker for colorectal cancer? Dis Colon Rectum. 1999 May;42(5):668-72.

Kanazawa M, Mori Y et al. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett. 2004 Feb 15;91(2-3):229-38.

Kantorova I, Lipska L et al. Routine (18)F-FDG PET preoperative staging of colorectal cancer: comparison with conventional staging and its impact on treatment decision making. J Nucl Med. 2003 Nov;44(11):1784-8.

Karlen P, Lofberg R et al. Increased risk of cancer in ulcerative colitis: a population-based cohort study. Am J Gastroenterol. 1999 Apr;94(4):1047-52.

Kato I, Dnistrian AM et al. Serum folate, homocysteine and colorectal cancer risk in women: a nested case-control study. Br J Cancer. 1999 Apr;79(11-12):1917-22.

Kelly MD, King J et al. Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes. Cancer. 1999 Apr 15;85(8):1658-63.

Khan A, Shrier I et al. The changed histologic paradigm of colorectal polyps. Surg Endosc. 2002;16(3):436-40.

Khosraviani K, Weir HP et al. Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut. 2002 Aug;51(2):195-9.

Kobayashi H, Matsunaga K et al. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev. 1995 Apr;4(3):275-81.

Kobayashi K, Matsumoto S et al. Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression 375. Cancer Res. 2000 Jul 15;60(14):3978-84.

Kontogiannea M, Gupta A et al. omega-3 fatty acids decrease endothelial adhesion of human colorectal carcinoma cells. J Surg Res. 2000 Aug;92(2):201-5.

Kos M, Dabrowski A. Tumour's angiogenesis--the function of VEGF and bFGF in colorectal cancer. Ann Univ Mariae Curie Sklodowska [Med ]. 2002;57(2):556-61.

Kowal M, Wojcierowski J. [Role and significance of DNA methylation]. PolMerkuriusz Lek. 2003 Apr;14(82):364-8.

Krauss H, Ignys I et al. Significance of the evaluation of the tissue proliferation specific marker (TPS) and the carcinoembryonal antigen (CEA) in patients with ulcerative colitis and adenocarcinoma. Med Sci Monit. 2002 Jan;8(1):CR48-CR51.

Kubota T, Fujiwara H et al. Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients. Br J Cancer. 2002 Apr 22;86(8):1257-61.

Kulkarni SD, Tilak JC et al. Evaluation of the antioxidant activity of wheatgrass (Triticum aestivum L.) as a function of growth under different conditions. Phytother Res. 2006 Mar;20(3):218-27.

Lamprecht SA, Lipkin M. Cellular mechanisms of calcium and vitamin D in the inhibition of colorectal carcinogenesis. Ann N Y Acad Sci. 2001 Dec;952:73-87.

Lasch K, Brasel C et al. [Selenium therapy in colorectal tumors?]. Med Klin (Munich). 1999 Oct 15;94 Suppl 3:97-100.

Lashner BA, Heidenreich PA et al. Effect of folate supplementation on the incidence of dysplasia and cancer in chronic ulcerative colitis. A case-control study. Gastroenterology. 1989 Aug;97(2):255-9.

Lashner BA, Provencher KS et al. The effect of folic acid supplementation on the risk for cancer or dysplasia in ulcerative colitis. Gastroenterology. 1997 Jan;112(1):29-32.

Latruffe N, Delmas D et al. Molecular analysis on the chemopreventive properties of resveratrol, a plant polyphenol microcomponent. Int J Mol Med. 2002 Dec;10(6):755-60.

Lau TN, Lo RH et al. Colorectal hepatic metastases: Role of radiofrequency ablation. Ann Acad Med Singapore. 2003 Mar;32(2):212-8.

Lawicki S, Mroczko B et al. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms]. Postepy Hig Med Dosw. 2002;56(5):617-34.

Lengauer C, Kinzler KW et al. DNA methylation and genetic instability in colorectal cancer cells. Proc Natl Acad Sci U S A. 1997 Mar 18;94(6):2545-50.

Leyon PV, Kuttan G. Studies on the role of some synthetic curcuminoid derivatives in the inhibition of tumour specific angiogenesis. J Exp Clin Cancer Res. 2003 Mar;22(1):77-83.

Liang YC, Tsai SH et al. Resveratrol-induced G2 arrest through the inhibition of CDK7 and p34CDC2 kinases in colon carcinoma HT29 cells. Biochem Pharmacol. 2003 Apr 1;65(7):1053-60.

Lieberman DA, Prindiville S et al. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA. 2003 Dec 10;290(22):2959-67.

Liljegren A, Lindblom A et al. Prevalence and incidence of hyperplastic polyps and adenomas in familial colorectal cancer: correlation between the two types of colon polyps. Gut. 2003 Aug;52(8):1140-7.

Louvet C, de GA. Pemetrexed in advanced colorectal cancer. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):56-62.

Lupton JR, Steinbach G et al. Calcium supplementation modifies the relative amounts of bile acids in bile and affects key aspects of human colon physiology. J Nutr. 1996 May;126(5):1421-8.

Lyn-Cook BD, Rogers T et al. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer. 1999;35(1):80-6.

Ma J, Pollak MN et al. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst. 1999 Apr 7;91(7):620-5.

Mahyar-Roemer M, Kohler H et al. Role of Bax in resveratrol-induced apoptosis of colorectal carcinoma cells. BMC Cancer. 2002 Oct 17;2(1):27.

Majewski S, Skopinska M et al. Vitamin D3 is a potent inhibitor of tumor cell-induced angiogenesis. J Investig Dermatol Symp Proc. 1996 Apr;1(1):97-101.

Malhotra SL. Faecal urobilinogen levels and pH of stools in population groups with different incidence of cancer of the colon, and their possible role in its aetiology. J R Soc Med. 1982 Sep;75(9):709-14.

Malmberg KJ, Lenkei R et al. A short-term dietary supplementation of high doses of vitamin E increases T helper 1 cytokine production in patients with advanced colorectal cancer. Clin Cancer Res. 2002 Jun;8(6):1772-8.

Mantzioris E, James MJ et al. Dietary substitution with an alpha-linolenic acid-rich vegetable oil increases eicosapentaenoic acid concentrations in tissues. Am J Clin Nutr. 1994 Jun;59(6):1304-9.

Markowitz AJ, Winawer SJ. Screening and surveillance for colorectal carcinoma. Hematol Oncol Clin North Am. 1997 Aug;11(4):579-608.

Marra G, Boland CR. Hereditary nonpolyposis colorectal cancer: the syndrome, the genes, and historical perspectives. J Natl Cancer Inst. 1995 Aug 2;87(15):1114-25.

Martinez ME, Giovannucci EL et al. Calcium, vitamin D, and the occurrence of colorectal cancer among women. J Natl Cancer Inst . 1996 Oct 2;88(19):1375-82.

Martinez ME, Heddens D et al. Physical activity, body mass index, and prostaglandin E2 levels in rectal mucosa. J Natl Cancer Inst. 1999 Jun 2;91(11):950-3.

Martinez ME, Marshall JR et al. Calcium, vitamin D, and risk of adenoma recurrence (United States). Cancer Causes Control. 2002 Apr;13(3):213-20.

Martinez ME, Giovannucci E et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer. 2006 Apr 13; [Epub ahead of print].

Mason JB. Nutritional chemoprevention of colon cancer. Semin Gastrointest Dis. 2002 Jul;13(3):143-53.

Mata JE, Yu Z et al. Effects of chlorophyllin on transport of dibenzo(a, l)pyrene, 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine, and aflatoxin B(1) across Caco-2 cell monolayers. Toxicology. 2004 Mar 1;196(1-2):117-25.

Matsumoto S, Imaeda Y et al. Cimetidine increases survival of colorectal cancer patients with high levels of sialyl Lewis-X and sialyl Lewis-A epitope expression on tumour cells. Br J Cancer. 2002 Jan 21;86(2):161-7.

Matsunaga K, Morita I et al. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals]. Gan To Kagaku Ryoho. 1986 Dec;13(12):3468-75.

Matsuura N, Miyamae Y. et al. Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr. 2006 Mar;136(3 Suppl):842S-846S.

Mavligit GM, Estrov Z. CA 125: a clinically useful tumor marker in the management of colorectal carcinoma metastatic to the liver in patients with normal carcinoembryonic antigen. Am J Clin Oncol. 2000 Apr;23(2):213-5.

McCarty MF. Fish oil may impede tumour angiogenesis and invasiveness by down-regulating protein kinase C and modulating eicosanoid production. Med Hypotheses. 1996 Feb;46(2):107-15.

McKeown-Eyssen GE, Yeung KS et al. Assessment of past diet in epidemiologic studies. Am J Epidemiol. 1986 Jul;124(1):94-103.

Melmon KL, Bourne HR et al. Receptors for histamine can be detected on the surface of selected leukocytes. Science. 1972 Aug 25;177(50):707-9.

Mesa RA. Tipifarnib: farnesyl transferase inhibition at a crossroads. Expert Rev Anticancer Ther. 2006 Mar;6(3):313-9.

Milde D, Novak O et al. Serum levels of selenium, manganese, copper, and iron in colorectal cancer patients. Biol Trace Elem Res. 2001 Feb;79(2):107-14.

Moragoda L, Jaszewski R et al. Curcumin induced modulation of cell cycle and apoptosis in gastric and colon cancer cells. Anticancer Res. 2001 Mar-Apr;21(2A):873-8.

Moran EM. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks. J Environ Pathol Toxicol Oncol. 2002;21(2):193-201.

Mueller-Klieser W, Schreiber-Klais S et al. Bioactivity of well-defined green tea extracts in multicellular tumor spheroids. Int J Oncol. 2002 Dec;21(6):1307-15.

Munkholm P. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther. 2003 Sep;18 Suppl 2:1-5.

Mutanen M, Pajari AM et al. Beef induces and rye bran prevents the formation of intestinal polyps in Apc(Min) mice: relation to beta-catenin and PKC isozymes. Carcinogenesis. 2000 Jun;21(6):1167-73.

Nagata C, Shimizu H et al. Cigarette smoking, alcohol use, and colorectal adenoma in Japanese men and women. Dis Colon Rectum. 1999 Mar;42(3):337-42.

Nagothu KK, Jaszewski R et al. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas. Cancer Detect Prev. 2003;27(4):297-304.

Nakagoe T, Sawai T et al. Preoperative serum level of CA19-9 predicts recurrence after curative surgery in node-negative colorectal cancer patients. Hepatogastroenterology. 2003 May;50(51):696-9.

Nakatsugi S, Fukutake M et al. Suppression of intestinal polyp development by nimesulide, a selective cyclooxygenase-2 inhibitor, in Min mice. Jpn J Cancer Res. 1997 Dec;88(12):1117-20.

Colorectal Cancer

References

Nangia-Makker P, Hogan V et al. Inhibition of human cancer cell growth and metastasis in nude mice by oral intake of modified citrus pectin. J Natl Cancer Inst. 2002 Dec 18;94(24):1854-62.

Neugut AI, Murray TI et al. Cholecystectomy as a risk factor for colorectal adenomatous polyps and carcinoma. Cancer. 1991 Oct 1;68(7):1644-7.

Neuzil J, Weber T et al. Induction of cancer cell apoptosis by alpha-tocopheryl succinate: molecular pathways and structural requirements. FASEB J. 2001 Feb;15(2):403-15.

Neuzil J. Vitamin E succinate and cancer treatment: a vitamin E prototype for selective antitumour activity. Br J Cancer. 2003 Nov 17;89(10):1822-6.

Newberne PM, Locniskar M. Roles of micronutrients in cancer prevention: recent evidence from the laboratory. Prog Clin Biol Res . 1990;346:119-34.

O'Brien MJ, Winawer SJ et al. The National Polyp Study. Patient and polyp characteristics associated with high-grade dysplasia in colorectal adenomas. Gastroenterology. 1990 Feb;98(2):371-9.

O'Neil BH, Goldberg RM. Novel chemotherapeutic and targeted agents in metastatic colorectal cancer: the time has arrived. Expert Opin Investig Drugs. 2003 Dec;12(12):1939-49.

Ohwada S, Ikeya T et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer. 2004 Mar 8;90(5):1003-10.

Okulczyk B, Piotrowski Z et al. Evaluation of K-RAS gene in colorectal cancer. Folia Histochem Cytobiol. 2003;41(2):97-100.

Oshima M, Dinchuk JE. et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996 Nov 29;87(5):803-9.

Otsuka S, Inagaki M et al. [Radiofrequency ablation therapy combined with intrahepatic arterial infusion chemotherapy for liver metastasis of colorectal cancer]. Gan To Kagaku Ryoho. 2003 Oct;30(11):1598-601.

Palmqvist R, Engaras B et al. Prediagnostic levels of carcinoembryonic antigen and CA 242 in colorectal cancer: a matched case-control study. Dis Colon Rectum. 2003 Nov;46(11):1538-44.

Pares A, Planas R et al. Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol. 1998 Apr;28(4):615-21.

Pawlik TM, Izzo F et al. Combined resection and radiofrequency ablation for advanced hepatic malignancies: results in 172 patients. Ann Surg Oncol. 2003 Nov;10(9):1059-69.

Peltomaki P, Vasen HF. Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer. Gastroenterology. 1997 Oct;113(4):1146-58.

Peng G, Dixon DA. et al. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog. 2006 May;45(5):309-19.

Perkins S, Verschoyle RD et al. Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol Biomarkers Prev. 2002 Jun;11(6):535-40.

Peters U, Chatterjee N et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006 Feb;15(2):315-20.

Pienta KJ, Naik H et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995 Mar 1;87(5):348-53.

Pierre F, Tache S et al. Meat and cancer: haemoglobin and haemin in a low-calcium diet promote colorectal carcinogenesis at the aberrant crypt stage in rats. Carcinogenesis. 2003;24(10):1683-90.

Pisters KM, Newman RA et al. Phase I trial of oral green tea extract in adult patients with solid tumors. J Clin Oncol. 2001 Mar 15;19(6):1830-8.

Platz EA, Giovannucci E et al. Dietary fiber and distal colorectal adenoma in men. Cancer Epidemiol Biomarkers Prev. 1997 Sep;6(9):661-70.

Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta. 2005 Nov 25;1756(2):83-96.

Pricolo VE, Finkelstein SD et al. Mutated p53 gene is an independent adverse predictor of survival in colon carcinoma. Arch Surg. 1997 Apr;132(4):371-4.

Provenzale D, Kowdley KV et al. Prophylactic colectomy or surveillance for chronic ulcerative colitis? A decision analysis. Gastroenterology. 1995 Oct;109(4):1188-96.

Psathakis D, Wedemeyer N et al. Blood selenium and glutathione peroxidase status in patients with colorectal cancer. Dis Colon Rectum. 1998 Mar;41(3):328-35.

Pufulete M, Al Ghnaniem R et al. Folate status, genomic DNA hypomethylation, and risk of colorectal adenoma and cancer: a case control study. Gastroenterology. 2003 May;124(5):1240-8.

Rao S, Cunningham D. et al. Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. J Clin Oncol. 2004 Oct 1;22(19):3950-7.

Reddy BS, Rao CV. Novel approaches for colon cancer prevention by cyclooxygenase-2 inhibitors. J Environ Pathol Toxicol Oncol. 2002;21(2):155-64.

Reddy S, Aggarwal BB. Curcumin is a non-competitive and selective inhibitor of phosphorylase kinase. FEBS Lett. 1994 Mar 14;341(1):19-22.

Reddy BS, Sharma C et al. Metabolic epidemiology of colon cancer: effect of dietary fiber on fecal mutagens and bile acids in healthy subjects. Cancer Res. 1987 Jan 15;47(2):644-8.

Reeves MJ, Newcomb PA et al. Nonsteroidal anti-inflammatory drug use and protection against colorectal cancer in women. Cancer Epidemiol Biomarkers Prev. 1996 Dec;5(12):955-60.

Reynolds JL, Akhter J et al. Histamine content in colorectal cancer. Are there sufficient levels of histamine to affect lymphocyte function? Eur J Surg Oncol. 1997 Jun;23(3):224-7.

Rigas B, Goldman IS et al. Altered eicosanoid levels in human colon cancer 1. J Lab Clin Med. 1993 Nov;122(5):518-23.

Robey RW, Steadman K et al. Pheophorbide a is a specific probe for ABCG2 function and inhibition. Cancer Res. 2004 Feb 15;64(4):1242-6.

Rocklin RE, Greineder DK et al. Histamine-induced suppressor factor (HSF): further studies on the nature of the stimulus and the cell which produces it. Cell Immunol. 1979 May;44(2):404-15.

Rozen P, Fireman Z et al. Oral calcium suppresses increased rectal epithelial proliferation of persons at risk of colorectal cancer 1158. Gut. 1989 May;30(5):650-5.

Rozen P, Lubin F et al. Calcium supplements interact significantly with long-term diet while suppressing rectal epithelial proliferation of adenoma patients. Cancer. 2001 Feb 15;91(4):833-40.

Rumi G, Jr., Szabo I et al. Decrease in serum levels of vitamin A and zeaxanthin in patients with colorectal polyp. Eur J Gastroenterol Hepatol. 1999 Mar;11(3):305-8.

Russo A, Franceschi S et al. Body size and colorectal-cancer risk 1. Int J Cancer. 1998 Oct 5;78(2):161-5.

Russo MW, Murray SC et al. Plasma selenium levels and the risk of colorectal adenomas. Nutr Cancer. 1997;28(2):125-9.

Salucci M, Stivala LA et al. Flavonoids uptake and their effect on cell cycle of human colon adenocarcinoma cells (Caco2). Br J Cancer. 2002 May 20;86(10):1645-51.

Sandler RS, Halabi S et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003 Mar 6;348(10):883-90.

Satia-Abouta J, Galanko JA, et al. Associations of micronutrients with colon cancer risk in African Americans and whites: results from the North Carolina Colon Cancer Study. Cancer Epidemiol Biomarkers Prev. 2003 Aug;12(8):747-54.

Schneider Y, Vincent F et al. Anti-proliferative effect of resveratrol, a natural component of grapes and wine, on human colonic cancer cells. Cancer Lett. 2000 Sep 29;158(1):85-91.

Schoen RE, Tangen CM, et al. Increased blood glucose and insulin, body size, and incident colorectal cancer. J Natl Cancer Inst. 1999 Jul 7;91(13):1147-54.

Sharma RA, McLelland HR et al. Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer. Clin Cancer Res. 2001 Jul;7(7):1894-900.

Sheehan KM, Sheahan K et al. The relationship between cyclooxygenase-2 expression and colorectal cancer. JAMA. 1999 Oct 6;282(13):1254-7.

Shibuya K, Mathers CD et al. Global and regional estimates of cancer mortality and incidence by site: II. Results for the global burden of disease 2000. BMC Cancer. 2002 Dec 26;2(1):37.

Simopoulos AP. The importance of the ratio of omega-6/omega-3 essential fatty acids. Biomed Pharmacother. 2002 Oct;56(8):365-79.

Singh J, Hamid R et al. Dietary fat and colon cancer: Modulating effect of types and amount of dietary fat on ras-p21 function during promotion and progression stages of colon cancer. Cancer Res. 1997;57(2):253-8.

Singh J, Hamid R et al. Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis. 1998 Jun;19(6):985-9.

Singh SV. Impact of garlic organosulfides on p21(H-ras) processing. J Nutr. 2001;131(3S):1046S-1048S.

Skrzypczak-Jankun E, Zhou K et al. Structure of curcumin in complex with lipoxygenase and its significance in cancer. Int J Mol Med. 2003 Jul;12(1):17-24.

Smith-Barbaro P, Hanson D et al. Carcinogen binding to various types of dietary fiber. J Natl Cancer Inst. 1981 Aug;67(2):495-7.

Stadler J, Stern HS et al. Effect of high fat consumption on cell proliferation activity of colorectal mucosa and on soluble faecal bile acids. Gut. 1988 Oct;29(10):1326-31.

Stangl R, Altendorf-Hofmann A et al. Factors influencing the natural history of colorectal liver metastases. Lancet. 1994 Jun 4;343(8910):1405-10.

Steinbach G, Morotomi M et al. Calcium reduces the increased fecal 1,2-sn-diacylglycerol content in intestinal bypass patients: a possible mechanism for altering colonic hyperproliferation. Cancer Res. 1994 Mar 1;54(5):1216-9.

Stierum R, Burgemeister R et al. Functional food ingredients against colorectal cancer. An example project integrating functional genomics, nutrition and health. Nutr Metab Cardiovasc Dis. 2001 Aug;11(4 Suppl):94-8.

Stoeltzing O, Liu W et al. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis. Ann Surg Oncol. 2003 Aug;10(7):722-33.

Stoner GD, Budd GT et al. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv Exp Med Biol. 1999;470:45-53.

Su CC, Chen GW et al. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res. 2006 Mar;26(2A):1281-8.

Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog. 2006 Jun;45(6):409-15.

Suzuki K, Bruce WR. Increase by deoxycholic acid of the colonic nuclear damage induced by known carcinogens in C57BL/6J mice. J Natl Cancer Inst. 1986 Jun;76(6):1129-32.

Szende B, Raso E et al. [A new benzoquinone-containing antimetastatic product]. Orv Hetil. 1998 Nov 29;139(48):2893-7.

Tajmir-Riahi HA, Neault JF et al. DNA adducts with chlorophyll and chlorophyllin as antimutagenic agents: synthesis, stability, and structural features. Methods Mol Biol. 2004;274:159-71.

Takahashi Y, Tucker SL et al. Vessel counts and expression of vascular endothelial growth factor as prognostic factors in node-negative colon cancer. Arch Surg. 1997 May;132(5):541-6.

Takashima S, Kinami Y et al. [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku] Gan To Kagaku Ryoho. 1988 Aug;15(8):2229-36.

Takeda A, Shimada H et al. [Detection of serum p53 antibodies in colorectal cancer patients and the clinical significance of postoperative monitoring]. Gan To Kagaku Ryoho. 1999 Dec;26(14):2189-94.

Tanaka S, Haruma K et al. Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study. Hiroshima J Med Sci. 2004 Dec;53(3-4):39-45.

Tanaka S, Haruma K et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 2006 Mar;136(3 Suppl):821S-826S.

Tang NH, Chen YL et al. Cooperative inhibitory effects of antisense oligonucleotide of cell adhesion molecules and cimetidine on cancer cell adhesion. World J Gastroenterol. 2004 Jan;10(1):62-6.

Tavani A, Fioretti F et al. Pilot study--cimetidine enhances lymphocyte infiltration of human colorectal carcinoma: results of a small randomized control trial. Cancer. 1998 Jun 1;82(11):2296-7.

Terry P, Baron JA et al. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer. 2002;43(1):39-46.

Thoma C, Green TJ et al. Citrus pectin and oligofructose improve folate status and lower serum total homocysteine in rats. Int J Vitam Nutr Res. 2003 Nov;73(6):403-9.

Thun MJ, Namboodiri MM, et al. Aspirin use and reduced risk of fatal colon cancer. N Engl J Med. 1991 Dec 5;325(23):1593-6.

Tournigand C, Andre T et al. FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study. J Clin Oncol. 2004 Jan 15;22(2):229-37.

Traverso G, Shuber A et al. Detection of proximal colorectal cancers through analysis of faecal DNA. Lancet. 2002 Feb 2;359(9304):403-4.

Tseng M, Murray SC et al. Micronutrients and the risk of colorectal adenomas. Am J Epidemiol. 1996 Dec 1;144(11):1005-14.

Tsujii M, Kawano S et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998 May 29;93(5):705-16.

Uchida A, Fukata H. Role of NK cell cytotoxic factor against fresh human tumors. Nat Immun. 1993 Jul;12(4-5):267-78.

van Gorkom BA, Karrenbeld A et al. Calcium or resistant starch does not affect colonic epithelial cell proliferation throughout the colon in adenoma patients: a randomized controlled trial. Nutr Cancer. 2002;43(1):31-8.

Vegan Society 2003. Essential Fatty Acids. http://www.vegansociety.com/html/food/nutrition/e_fatty_acids.php. Accessed June 23, 2006.

vivi-Green C, Polak-Charcon S et al. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition. Oncol Res. 2000;12(2):83-95.

Vogelstein B, Fearon ER et al. Genetic alterations during colorectal-tumor development. N Engl J Med. 1988 Sep 1;319(9):525-32.

Wallace K, Byers T et al. Prediagnostic serum selenium concentration and the risk of recurrent colorectal adenoma: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2003 May;12(5):464-7.

Walle T, Hsieh F. et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004 Dec;32(12):1377-82.

Wang JY, Hsieh JS et al. High frequency of activated K-ras codon 15 mutant in colorectal carcinomas from Taiwanese patients. Int J Cancer. 2003 Nov 10;107(3):387-93.

Wargovich MJ, Isbell G et al. Calcium supplementation decreases rectal epithelial cell proliferation in subjects with sporadic adenoma. Gastroenterology. 1992 Jul;103(1):92-7.

Watson P, Lin KM et al. Colorectal carcinoma survival among hereditary nonpolyposis colorectal carcinoma family members. Cancer. 1998 Jul 15;83(2):259-66.

Weber T, Lu M et al. Vitamin E succinate is a potent novel antineoplastic agent with high selectivity and cooperativity with tumor necrosis factor-related apoptosis-inducing ligand (Apo2 ligand) in vivo. Clin Cancer Res. 2002 Mar;8(3):863-9.

Weir HK, Thun MJ et al. Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control 471. J Natl Cancer Inst. 2003 Sep 3;95(17):1276-99.

Welfare MR, Cooper J et al. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England 474. Carcinogenesis. 1997 Jul;18(7):1351-4.

Whelan RL, Horvath KD et al. Vitamin and calcium supplement use is associated with decreased adenoma recurrence in patients with a previous history of neoplasia. Dis Colon Rectum. 1999 Feb;42(2):212-7.

Wilson LC, Baek SJ et al. Nonsteroidal anti-inflammatory drug-activated gene (NAG-1) is induced by genistein through the expression of p53 in colorectal cancer cells. Int J Cancer. 2003 Jul 20;105(6):747-53.

Winawer SJ, St John J et al. Screening of average-risk individuals for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ. 1990;68(4):505-13.

Winawer SJ, Shike M. Dietary factors in colorectal cancer and their possible effects on earlier stages of hyperproliferation and adenoma formation 473. J Natl Cancer Inst. 1992 Jan 15;84(2):74-5.

Winawer SJ, Zauber AG et al. Prevention of Colorectal Cancer by Colonoscopic Polypectomy. N Engl J Med. 1993 Dec 30;329(27):1977-81.

Yachida S, Fukushima N et al. Alpha-fetoprotein-producing carcinoma of the colon: report of a case and review of the literature. Dis Colon Rectum. 2003 Jun;46(6):826-31.

Yamamoto Y, Yin MJ et al. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem. 1999 Sep 17;274(38):27307-14.

Yarbro JW, Page DL et al. American Joint Committee on Cancer prognostic factors consensus conference. Cancer. 1999 Dec 1;86(11):2436-46.

Yoshimatsu K, Ishibashi K et al. [Effect of cimetidine with chemotherapy on stage IV colorectal cancer]. Gan To Kagaku Ryoho. 2003 Oct;30(11):1794-7.

Zaniboni A, Torri V et al. Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey. Tumori. 2005 Sep;91(5):383-7.

Zeng Z, Cohen AM et al. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer. 1992 Aug 15;70(4):737-40.

Zhang SM, Moore SC et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2006 Jan 15;163(2):108-15.

Zhong SS, Zhang ZS et al. [Study of angiogenesis in human colorectal carcinoma and its modulation by p53 and K-ras gene]. Zhonghua Nei Ke Za Zhi. 2003 Feb;42(2):77-80.

Atkins JN, Jacobs SA. et al. Pemetrexed/oxaliplatin for first-line treatment of patients with advanced colorectal cancer: a phase II trial of the National Surgical Adjuvant Breast and Bowel Project Foundation Research Program. Clin Colorectal Cancer. 2005 Sep;5(3):181-7.

Baron JA, Cole BF. et al. A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med. 2003 Mar 6;348(10):891-9.

Bingham S. The fibre-folate debate in colo-rectal cancer. Proc Nutr Soc. 2006 Feb;65(1):19-23.

Broitman SA, Wilkinson J. et al. Effects of monoterpenes and mevinolin on murine colon tumor CT-26 in vitro and its hepatic "metastases" in vivo. Adv Exp Med Biol 1996;401:111-30. 1995;401:111-30.

Castagnola P, Giaretti W. Mutant KRAS, chromosomal instability and prognosis in colorectal cancer. Biochim Biophys Acta. 2005 Nov 25;1756(2):115-25.

Castellone MD, Teramoto H. et al. Prostaglandin E2 promotes colon cancer cell growth through a Gs-axin-beta-catenin signaling axis. Science. 2005 Dec 2;310(5753):1504-10.

Chan TA. Prostaglandins and the colon cancer connection. Trends Mol Med. 2006 Apr 28.

Chan TA, Morin PJ. et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20a;95(2):681-6.

Chan TA, Morin PJ. et al. Mechanisms underlying nonsteroidal antiinflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A. 1998 Jan 20b;95(2):681-6.

Collett ED, Davidson LA. et al. n-6 and n-3 polyunsaturated fatty acids differentially modulate oncogenic Ras activation in colonocytes. Am J Physiol Cell Physiol. 2001 May;280(5):C1066-C1075.

Connelly-Frost A, Poole C. et al. Selenium, apoptosis, and colorectal adenomas. Cancer Epidemiol Biomarkers Prev. 2006 Mar;15(3):486-93.

Doxey BW, Kuwada SK. et al. Inherited polyposis syndromes: molecular mechanisms, clinicopathology, and genetic testing. Clin Gastroenterol Hepatol. 2005 Jul;3(7):633-41.

Eberhart CE, Coffey RJ. et al. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology. 1994 Oct;107(4):1183-8.

Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer]. Orv Hetil. 2005 Sep 11a;146(37):1925-31.

Farkas E. [Fermented wheat germ extract in the supportive therapy of colorectal cancer]. Orv Hetil. 2005 Sep 11b;146(37):1925-31.

Finley JW. Bioavailability of selenium from foods. Nutr Rev. 2006 Mar;64(3):146-51.

Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Anticancer Res. 2002 May;22(3):1737-54.

Fujiki H, Suganuma M. et al. Cancer inhibition by green tea. Mutat Res. 1998 Jun 18;402(1-2):307-10.

Garami M, Schuler D. et al. Fermented wheat germ extract reduces chemotherapy-induced febrile neutropenia in pediatric cancer patients. J Pediatr Hematol Oncol. 2004 Oct;26(10):631-5.

Garcea G, Berry DP. et al. Consumption of the putative chemopreventive agent curcumin by cancer patients: assessment of curcumin levels in the colorectum and their pharmacodynamic consequences. Cancer Epidemiol Biomarkers Prev. 2005 Jan;14(1):120-5.

Gelb MH, Tamanoi F. et al. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol. Cancer Lett 1995 May 8;91(2):169-75. 1995;91(2):169-75.

Glinskii OV, Huxley VH. et al. Mechanical entrapment is insufficient and intercellular adhesion is essential for metastatic cell arrest in distant organs. Neoplasia. 2005 May;7(5):522-7.

Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006 Febb;9(1A):124-6.

Gonzalez CA. The European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr. 2006 Feba;9(1A):124-6.

Hanif R, Pittas A. et al. Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway. Biochem Pharmacol. 1996 Jul 26;52(2):237-45.

He TC, Chan TA. et al. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 Oct 29a;99(3):335-45.

He TC, Chan TA. et al. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 Oct 29b;99(3):335-45.

Hidvegi M, Raso E. et al. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 1998 Jula;18(4A):2353-8.

Hidvegi M, Raso E. et al. Effect of Avemar and Avemar + vitamin C on tumor growth and metastasis in experimental animals. Anticancer Res. 1998 Julb;18(4A):2353-8.

Hidvegi M, Raso E. et al. MSC, a new benzoquinone-containing natural product with antimetastatic effect. Cancer Biother Radiopharm. 1999 Aug;14(4):277-89.

Holla VR, Mann JR. et al. Prostaglandin E2 regulates the nuclear receptor NR4A2 in colorectal cancer. J Biol Chem. 2006 Feb 3;281(5):2676-82.

Ide T, Horii M. et al. Contrasting effects of water-soluble and water-insoluble dietary fibers on bile acid conjugation and taurine metabolism in the rat. Lipids. 1990 Jun;25(6):335-40.

Illmer C, Madlener S. et al. Immunologic and biochemical effects of the fermented wheat germ extract Avemar. Exp Biol Med (Maywood ). 2005 Feb;230(2):144-9.

Ishikawa H, Saeki T. et al. Aged garlic extract prevents a decline of NK cell number and activity in patients with advanced cancer. J Nutr. 2006 Mar;136(3 Suppl):816S-20S.

Jakab F, Mayer A. et al. First clinical data of a natural immunomodulator in colorectal cancer. Hepatogastroenterology. 2000 Mar;47(32):393-5.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15a;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15b;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15c;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15d;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15e;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15f;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15g;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15h;21(4):321-39.

Jalving M, Koornstra JJ. et al. Review article: the potential of combinational regimen with non-steroidal anti-inflammatory drugs in the chemoprevention of colorectal cancer. Aliment Pharmacol Ther. 2005 Feb 15i;21(4):321-39.

Janne PA, Mayer RJ. Chemoprevention of colorectal cancer. N Engl J Med. 2000 Jun 29;342(26):1960-8.

Jiao Y, Wilkinson J. et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006 Apr 1a;40(7):1152-60.

Jiao Y, Wilkinson J. et al. Iron chelation in the biological activity of curcumin. Free Radic Biol Med. 2006 Apr 1b;40(7):1152-60.

Jubb AM, Hurwitz HI. et al. Impact of vascular endothelial growth factor-A expression, thrombospondin-2 expression, and microvessel density on the treatment effect of bevacizumab in metastatic colorectal cancer. J Clin Oncol. 2006 Jan 10;24(2):217-27.

Kanazawa M, Mori Y. et al. Effect of PSK on the maturation of dendritic cells derived from human peripheral blood monocytes. Immunol Lett. 2004 Feb 15;91(2-3):229-38.

Kobayashi H, Matsunaga K. et al. Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview. Cancer Epidemiol Biomarkers Prev. 1995 Apr;4(3):275-81.

Kulkarni SD, Tilak JC. et al. Evaluation of the antioxidant activity of wheatgrass (Triticum aestivum L.) as a function of growth under different conditions. Phytother Res. 2006 Mar;20(3):218-27.

Louvet C, de GA. Pemetrexed in advanced colorectal cancer. Oncology (Williston Park). 2004 Nov;18(13 Suppl 8):56-62.

Lyn-Cook BD, Rogers T. et al. Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro. Nutr Cancer 1999;35(1):80-6. 1999;35(1):80-6.

Martinez ME, Giovannucci E. et al. Folate fortification, plasma folate, homocysteine and colorectal adenoma recurrence. Int J Cancer. 2006 Apr 13.

Matsunaga K, Morita I. et al. [Restoration of immunologic responsiveness by PSK in tumor-bearing animals]. Gan To Kagaku Ryoho. 1986 Dec;13(12):3468-75.

Matsuura N, Miyamae Y. et al. Aged garlic extract inhibits angiogenesis and proliferation of colorectal carcinoma cells. J Nutr. 2006 Mar;136(3 Suppl):842S-6S.

Mesa RA. Tipifarnib: farnesyl transferase inhibition at a crossroads. Expert Rev Anticancer Ther. 2006 Mar;6(3):313-9.

Ohwada S, Ikeya T. et al. Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study. Br J Cancer. 2004 Mar 8;90(5):1003-10.

Oshima M, Dinchuk JE. et al. Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell. 1996 Nov 29;87(5):803-9.

Peng G, Dixon DA. et al. Green tea polyphenol (-)-epigallocatechin-3-gallate inhibits cyclooxygenase-2 expression in colon carcinogenesis. Mol Carcinog. 2006 May;45(5):309-19.

Peters U, Chatterjee N. et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006 Feba;15(2):315-20.

Peters U, Chatterjee N. et al. High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev. 2006 Febb;15(2):315-20.

Pienta KJ, Naik H. et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst. 1995 Mar 1;87(5):348-53.

Pretlow TP, Pretlow TG. Mutant KRAS in aberrant crypt foci (ACF): initiation of colorectal cancer? Biochim Biophys Acta. 2005 Nov 25;1756(2):83-96.

Rao S, Cunningham D. et al. Phase III double-blind placebo-controlled study of farnesyl transferase inhibitor R115777 in patients with refractory advanced colorectal cancer. J Clin Oncol. 2004 Oct 1;22(19):3950-7.

Sandler RS, Halabi S. et al. A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med. 2003 Mar 6;348(10):883-90.

Singh J, Hamid R. et al. Dietary fish oil inhibits the expression of farnesyl protein transferase and colon tumor development in rodents. Carcinogenesis. 1998 Jun;19(6):985-9.

Singh SV. Impact of garlic organosulfides on p21(H-ras) processing. J Nutr. 2001;131(3S):1046S-8S.

Smith-Barbaro P, Hanson D. et al. Carcinogen binding to various types of dietary fiber. J Natl Cancer Inst. 1981 Aug;67(2):495-7.

Stoner GD, Budd GT. et al. Sulindac sulfone induced regression of rectal polyps in patients with familial adenomatous polyposis. Adv Exp Med Biol. 1999;470:45-53.

Su CC, Chen GW. et al. Curcumin inhibits cell migration of human colon cancer colo 205 cells through the inhibition of nuclear factor kappa B /p65 and down-regulates cyclooxygenase-2 and matrix metalloproteinase-2 expressions. Anticancer Res. 2006 Mar;26(2A):1281-8.

Sun Y. p53 and its downstream proteins as molecular targets of cancer. Mol Carcinog. 2006 May 1.

Szende B, Raso E. et al. [A new benzoquinone-containing antimetastatic product]. Orv Hetil. 1998 Nov 29;139(48):2893-7.

Tanaka S, Haruma K. et al. Effects of aged garlic extract (AGE) on colorectal adenomas: a double-blinded study. Hiroshima J Med Sci. 2004 Dec;53(3-4):39-45.

Tanaka S, Haruma K. et al. Aged garlic extract has potential suppressive effect on colorectal adenomas in humans. J Nutr. 2006 Mar;136(3 Suppl):821S-6S.

Tsujii M, Kawano S. et al. Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell. 1998 May 29;93(5):705-16.

vivi-Green C, Polak-Charcon S. et al. Apoptosis cascade proteins are regulated in vivo by high intracolonic butyrate concentration: correlation with colon cancer inhibition. Oncol Res. 2000;12(2):83-95.

Walle T, Hsieh F. et al. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab Dispos. 2004 Dec;32(12):1377-82.

Yamamoto Y, Yin MJ. et al. Sulindac inhibits activation of the NF-kappaB pathway. J Biol Chem. 1999 Sep 17;274(38):27307-14.

Zaniboni A, Torri V. et al. Neoadjuvant oxaliplatin-based chemotherapy for liver metastases from colorectal cancer. An Italian survey. Tumori. 2005 Sep;91(5):383-7.

Zhang SM, Moore SC. et al. Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol. 2006 Jan 15;163(2):108-15.